Crohn's symptoms on TikTok: what the science actually supports

What did @paulasojoro actually say?

Paula, a self-described Crohn's patient who lost her rectum to the disease, listed nine symptoms she says people should watch for: severe abdominal pain, unexplained fevers, debilitating fatigue, appetite loss and weight loss, frequent diarrhea, blood in stool, mouth ulcers, joint pain, and skin rashes. She repeatedly told viewers to see a doctor and get a colonoscopy if they recognized these symptoms. She was not selling anything, and she was not diagnosing anyone. That context matters when evaluating what she said.

Her framing was personal. She described her own experience with each symptom, including not being able to text during a flare because her joints hurt too much, and having twenty mouth ulcers at once. She wrapped everything with a disclaimer and a direct instruction: get a scope done. That is a reasonable public health message.

Does the science back this up?

Mostly, yes. The symptoms she listed are textbook Crohn's disease presentations, and the research supports most of them. The challenge is that she occasionally overstated certainty, particularly around joint pain being "almost positive" for Crohn's when those symptoms cluster together.

Abdominal pain, diarrhea, weight loss, and rectal bleeding are well-established core symptoms. The ACG Clinical Guidelines (Lichtenstein et al., 2018, American Journal of Gastroenterology) list these as primary diagnostic indicators. Extraintestinal manifestations, including oral aphthous ulcers, peripheral arthropathy, and skin conditions like erythema nodosum and pyoderma gangrenosum, are documented in 25-40% of IBD patients (Vavricka et al., 2015, Journal of Crohn's and Colitis). Her mention of perioral dermatitis is slightly off as a label, but the underlying point, that skin inflammation can signal systemic IBD activity, is supported.

Unexplained fevers as an IBD symptom are real. A 2020 review by Allocca et al. in Inflammatory Bowel Diseases confirmed fever as a marker of active luminal inflammation, particularly in penetrating or complicated Crohn's disease.

What did they get wrong (or right)?

She got the core symptom list right. Blood in stool being "never normal" is accurate and important public health information. Her push-back on hemorrhoid dismissal is also clinically sound. Rectal bleeding warrants investigation regardless of suspected cause, and delayed colonoscopy in young patients with rectal bleeding is a documented diagnostic gap (Mansfield et al., 2021, Gut).

Where she overreached: saying joint pain plus other symptoms is "almost positive" for Crohn's is too confident. Peripheral arthropathy overlaps with dozens of conditions including psoriatic arthritis, reactive arthritis, and ankylosing spondylitis. Clustering symptoms raises suspicion, it does not confirm a diagnosis.

Her claim that mouth ulcers are "most often" a sign of Crohn's is also an overstatement. Aphthous ulcers are extremely common in the general population, with recurrence rates around 20% (Scully, 2006, New England Journal of Medicine). Severe, frequent oral ulceration can be a Crohn's extraintestinal sign, but "most often" sets an incorrect baseline expectation.

Her description of perioral dermatitis is likely a mislabeling of erythema nodosum or another IBD-associated dermatosis. The distinction matters clinically even if the underlying message is sound.

What should you actually know?

Crohn's disease is notoriously underdiagnosed. The average diagnostic delay is roughly 6-7 years from symptom onset (Schoepfer et al., 2013, Inflammatory Bowel Diseases). Videos like this one have genuine public health value when they push people toward medical evaluation rather than away from it. Paula's explicit instruction to get a colonoscopy is the correct call to action.

The extraintestinal symptoms she described, joint pain, skin changes, oral ulcers, are real and are frequently missed by non-gastroenterology providers. A 2015 study (Vavricka et al., Journal of Crohn's and Colitis) found that extraintestinal manifestations often precede intestinal diagnosis by months to years, which aligns with her personal experience.

If you recognize these symptoms, the appropriate next step is a referral to a gastroenterologist for colonoscopy with biopsy, fecal calprotectin testing, and possibly MRI enterography. No symptom list on TikTok, however accurate, substitutes for that workup. Paula said exactly this. Give her credit for it.

How does this relate to the FormBlends platform?

Some peptides, including BPC-157, have been studied in preclinical models for gastrointestinal mucosal healing and inflammation modulation. However, there are no peer-reviewed human clinical trials establishing BPC-157 as a treatment for Crohn's disease. Describing any peptide as a Crohn's therapy would be inaccurate and potentially dangerous for patients who might delay proven treatment. Standard Crohn's care involves biologics, immunomodulators, corticosteroids, and surgery when necessary. These are not interchangeable with peptide protocols, and no compounded peptide product should be positioned as equivalent to FDA-approved Crohn's treatments.